We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+32.42%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$703M
AUM Growth
+$202M
Cap. Flow
+$117M
Cap. Flow %
16.67%
Top 10 Hldgs %
43.13%
Holding
134
New
60
Increased
28
Reduced
13
Closed
31

Top Buys

Rank Stock Value
1
ZBH icon
Zimmer Biomet
ZBH
+$12.9M
2
XRAY icon
Dentsply Sirona
XRAY
+$9.25M
3
BSX icon
Boston Scientific
BSX
+$7.14M
4
VRAY
ViewRay, Inc.
VRAY
+$7.09M
5
GILD icon
Gilead Sciences
GILD
+$6.65M

Top Sells

Rank Stock Value
1
SIBN icon
SI-BONE Inc
SIBN
+$4.49M
2
AMGN icon
Amgen
AMGN
+$3.89M
3
ALXN
Alexion Pharmaceuticals
ALXN
+$3.33M
4
TNDM icon
Tandem Diabetes Care
TNDM
+$2.99M
5
AMRN
Amarin Corp
AMRN
+$2.78M

Sector Composition

Rank Sector Weight
1 Healthcare 36.29%
2 Industrials 0.63%
3 Financials 0.27%
4 Technology 0.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DXCM icon
26
DexCom
DXCM
$33.4B
$7.72M 1.1%
259,148
-30,852
-11% -$1.08M
ALGN icon
27
PUT
Align Technology
ALGN
$12.3B
$7.11M 1.01%
+25,000
New +$5.97M
AXGN icon
28
Axogen
AXGN
$2.62B
$6.79M 0.97%
+322,500
New +$5.89M
IVC
29
DELISTED
Invacare Corporation
IVC
$6.58M 0.94%
+786,439
New +$5.66M
NSTG
30
CALL
DELISTED
NanoString Technologies, Inc.
NSTG
$6.58M 0.94%
275,000
-53,800
-16% -$1.24M
GILD icon
31
Gilead Sciences
GILD
$169B
$6.5M 0.92%
+100,000
New +$6.65M
AXGN icon
32
CALL
Axogen
AXGN
$2.62B
$6.32M 0.9%
+300,000
New +$5.48M
XENT
33
DELISTED
Intersect ENT, Inc
XENT
$6.3M 0.9%
195,826
+5,491
+3% +$170K
AGN
34
DELISTED
Allergan plc
AGN
$6.17M 0.88%
42,125
+22,125
+111% +$3.21M
DHR icon
35
Danaher
DHR
$146B
$5.94M 0.84%
+50,760
New +$5.2M
OFIX icon
36
Orthofix Medical
OFIX
$430M
$5.92M 0.84%
105,000
+92,262
+724% +$5.18M
ABMD
37
CALL
DELISTED
Abiomed Inc
ABMD
$5.71M 0.81%
+20,000
New +$6.65M
BAX icon
38
Baxter International
BAX
$14.4B
$5.69M 0.81%
70,000
+6,000
+9% +$437K
EXAS
39
PUT
DELISTED
Exact Sciences
EXAS
$5.63M 0.8%
+65,000
New +$5.53M
IRTC icon
40
PUT
iRhythm Holdings
IRTC
$4.03B
$5.62M 0.8%
+75,000
New +$6.41M
LAB icon
41
Standard BioTools
LAB
$313M
$5.58M 0.79%
420,000
-258,596
-38% -$2.73M
DVA icon
42
PUT
DaVita
DVA
$11.5B
$5.43M 0.77%
+100,000
New +$5.53M
KIDS icon
43
OrthoPediatrics
KIDS
$636M
$5.31M 0.75%
120,000
+3,169
+3% +$121K
AMRN
44
Amarin Corp
AMRN
$298M
$4.88M 0.69%
11,760
-7,714
-40% -$2.78M
BMY icon
45
CALL
Bristol-Myers Squibb
BMY
$130B
$4.77M 0.68%
+100,000
New +$4.98M
ARAY icon
46
CALL
Accuray
ARAY
$36.1M
$4.77M 0.68%
+1,000,000
New +$4.55M
CELG
47
DELISTED
Celgene Corp
CELG
$4.72M 0.67%
+50,000
New +$4.37M
XBI icon
48
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.4B
$4.53M 0.64%
+50,000
New +$4.25M
MASI
49
DELISTED
Masimo
MASI
$4.49M 0.64%
32,500
+24,717
+318% +$3.1M
RCM
50
DELISTED
R1 RCM Inc. Common Stock
RCM
$4.42M 0.63%
457,141
+421,858
+1,196% +$3.82M
1
2
3 4 5

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q1 2019 Portfolio in Review

As of Q1 2019, Pura Vida Investments held 134 positions worth $703M, up 40% from $501M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Pura Vida Investments deployed $117M of net new capital in Q1 2019, opening 60 new positions and adding to 28 existing holdings. Its largest new stake was Zimmer Biomet: 113,300 shares worth $14M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 28% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Tandem Diabetes Care, an estimated $2.99M trimmed.

  • Pura Vida Investments's largest Q1 2019 buy was Zimmer Biomet: 113,300 shares worth $14M.
  • Pura Vida Investments added most to Boston Scientific in Q1 2019, an estimated $7.14M increase.
  • Pura Vida Investments's biggest Q1 2019 reduction was Tandem Diabetes Care, cutting an estimated $2.99M.
  • Pura Vida Investments fully exited SI-BONE Inc in Q1 2019, selling an estimated $4.49M.
  • Pura Vida Investments's ten largest holdings make up 43% of its $703M portfolio in Q1 2019.
  • Pura Vida Investments opened 60 new positions and closed 31 in Q1 2019.
  • Pura Vida Investments's portfolio value rose 40% quarter-over-quarter to $703M.

Based on Pura Vida Investments's 13F filing for Q1 2019, filed 14 May 2019.